Skip to content

Improvement effects on scalp and hair by medicated hair restorer containing 5 kinds of active ingredients

Improvement effects on scalp and hair by medicated hair restorer containing 5 kinds of active ingredients: single blinded study - Improvement effects on scalp and hair by medicated hair restorer containing 5 kinds of active ingredients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000046532
Enrollment
26
Registered
2022-01-06
Start date
2022-01-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Using test article for 4 consecutive weeks Life as usual for a certain period of time

Sponsors

Japan Clinical Trial Association
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Subjects who feel that hair has become thin 2.Males from "Type II" to "Type IV" in the Hamilton-Norwood classification 3.Females from "I-2" to "I-4" in Olsen (Christmas tree) type

Exclusion criteria

Exclusion criteria: 1.Subjects with rash and inflammation throughout the scalp 2.Subjects planning to receive treatment or special treatment on AGA,FPHL treatment and scalp, hair during the study period 3.Subjects who plan to start new use and intake of hair restorer and food related to hair growth during the test period 4.Subjects with cosmetic allergies 5.Subjects who is participating in other human exams within the past 4 weeks 6.Subjects who are judged as unsuitable for the study by the investigator for the other reason

Design outcomes

Primary

MeasureTime frame
evaluation of scalp condition, hair thickness measurement

Secondary

MeasureTime frame
subjective assessment

Countries

Japan

Contacts

Public ContactTakeshi Kaneko

Japan Clinical Trial Association N.A.

info@yakujihou.org0364574666

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026